You are here

Netflix model

CMS approves Louisiana's 'Netflix model' with Gilead for hepatitis C drugs

Biopharma Dive

Wed, 06/26/19 - 11:49 pm

Gilead Sciences

June 14 P&P Quick Takes: Washington state approved for subscription HCV model; plus Merck and IBM, BGI, and more

BioCentury

Sat, 06/15/19 - 05:54 pm

AbbVie wins hep C contract with Washington state in latest 'Netflix' deal

Biopharma Dive

Fri, 04/26/19 - 07:45 pm

Washington state

Louisiana has picked its 'Netflix' hepatitis C partner: Gilead's new generics unit

Fierce Pharma

Wed, 03/27/19 - 11:45 am

Gilead Sciences

Asegua Therapeutics

Louisiana's 'Netflix' deal for hepatitis C drugs wins bids from AbbVie, Gilead and Merck

Fierce Pharma

Thu, 03/7/19 - 09:19 pm

Gilead Sciences